1-11 of 11
Jörg Cammenga, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers; The Prospective Nordic Study NMDSG14B

Magnus Tobiasson, MD, Tatjana Pandzic, PhD, Johanna Illman, Lars Nilsson, PhD, Simone Weström, Daniel Olsson, Elisabeth Ejerblad, MD, Astrid Olsnes Kittang, Gitte Olesen, Olle Werlenius, Andreas T Björklund, MD PhD MSc, Fryderyk Lorentz, Bengt Erik Holger Rasmussen, Jörg Cammenga, MD, Duruta Weber, Marios Dimitriou, PhD, Soili Kytölä, PhD, Gunilla Walldin, Kirsten Groenbaek, MD DMSc, Stephan Mielke, MD, Sten Eirik Waelgaard Jacobsen, MD PhD, Freja Ebeling, MD PhD, Lucia Cavelier, PhD, Lone Smidstrup Friis, MD PhD, Ingunn Dybedal, MD PhD, Eva Hellstrom Lindberg, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-138782
Published: 2020
Journal Articles

Impact of Donor-Derived CD34+ Infused Cell Dose on Outcomes of Patients Undergoing Allo-HCT Following Reduced Intensity Regimen for Myelofibrosis:a Study from the Chronic Malignancies Working Party of the EBMT

Tomasz Czerw, MD, Vittoria Malpassuti, Simona Iacobelli, Linda Koster, Nicolaus Kröger, Marie Robin, MD, Johan Maertens, Patrice Chevallier, MD, Stephan Mielke, MD, Xavier Poire, John A Snowden, BSc (Hons), MBChB, MD FRCP, FRCPath, Eefke J. Petersen, MD PhD, Ram Malladi, Didier Blaise, MD PhD, Péter Reményi, MD, Virginie Gandemer, MD PhD, Jörg Cammenga, MD, Marie Thérèse Rubio, Sébastien Maury, MD PhD, Eric Deconinck, MD PhD, Damian Finnegan, Patrick Hayden, Juan Carlos Hernandez Boluda, Donal P. McLornan, MB, BCh (Hons), MRCP, PhD FRCPath, Ibrahim Yakoub-Agha, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3338.
https://doi.org/10.1182/blood-2019-123827
Published: 2019
Journal Articles

Opposing Pathogenesis of Germline SAMD9/SAMD9L Variants in Adult Myelodysplastic Syndrome (MDS)

Yasunobu Nagata, Satoshi Narumi, MD PhD, Yihong Guan, Bartlomiej P. Przychodzen, Cassandra M. Hirsch, Hideki Makishima, MD PhD, Hirohito Shima, Victor Pastor Loyola, MSc, Teodora Kuzmanovic, BA, Tomas Radivoyevitch, PhD, Vera Adema, PhD, Hassan Awada, MD, Kenichi Yoshida, MD PhD, Francesc Sole, PhD, Babal K. Jha, Rabi Hanna, MD, Thomas Laframboise, PhD, Seishi Ogawa, MD PhD, Mikkael A. Sekeres, MD MS, Marcin W. Wlodarski, MD PhD, Jorg Cammenga, MD, Jaroslaw P. Maciejewski
Journal: Blood
Blood (2018) 132 (Supplement 1): 4351.
https://doi.org/10.1182/blood-2018-99-119896
Published: 2018
Journal Articles

Germline SAMD9 and SAMD9L Alterations in Adult Myelodysplastic Syndromes

Yasunobu Nagata, MD PhD, Bartlomiej P. Przychodzen, MSc, Cassandra M. Hirsch, BS, Hideki Makishima, MD PhD, Victor Pastor Loyola, MSc, Babal K Jha, PhD, Teodora Kuzmanovic, BA, Tomas Radivoyevitch, PhD, Vera Adema, PhD, Kenichi Yoshida, MD PhD, Samuel Li, BA, Francesc Sole, PhD, Thomas Laframboise, PhD, Rabi Hanna, MD, Mikkael A. Sekeres, MD MS, Seishi Ogawa, MD PhD, Marcin W. Wlodarski, MD PhD, Jorg Cammenga, MD, Jaroslaw P. Maciejewski, PhD MD FACP
Journal: Blood
Blood (2017) 130 (Supplement 1): 1670.
https://doi.org/10.1182/blood.V130.Suppl_1.1670.1670
Published: 2017
Journal Articles

Up-Regulation of Flt3 Is a Passive Event in Hoxa9/Meis1-Induced Acute Myeloid Leukemia

Anna Staffas, PhD, Yuan Wei, MD PhD, Laleh Arabanian, Ann Jansson, Sara Ståhlman, Susanne Li, Linda Fogelstrand, MD PhD, Jörg Cammenga, MD PhD, Florian Kuchenbauer, MD PhD, Lars Palmqvist, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2441.
https://doi.org/10.1182/blood.V126.23.2441.2441
Published: 2015
Journal Articles

Tumor Suppressor Role of HIF-1alpha in Leukemia-Initiating Cells in Flt3-ITD-Induced Myeloproliferative Neoplasm

Talia Velasco, PhD, Jörg Cammenga, MD
Journal: Blood
Blood (2014) 124 (21): 3578.
https://doi.org/10.1182/blood.V124.21.3578.3578
Published: 2014
Journal Articles

Hematopoietic Stem Cells Are Intrinsically Protected Against MLL-ENL Mediated Transformation

Amol Sanjay Ugale, Gudmundur Logi Norddahl, Martin Wahlestedt, Petter Säwén, Pekka Jaako, PhD, Cornelis J.H. Pronk, MDPhD, Shamit Soneji, PhD, Jorg Cammenga, MD PhD, David Bryder, PhD
Journal: Blood
Blood (2014) 124 (21): 839.
https://doi.org/10.1182/blood.V124.21.839.839
Published: 2014
Journal Articles

Down-Regulation of CEBPA Expression Has a Stronger Impact on Myeloid Differentiation in Human Versus Mouse Cells: Mechanistic Implications for CEBPA Mutations in AML.

Gabriela Bernadeta Iwanski, MD, Birte Niebuhr, Maike Täger, PhD, Susanne Roscher, Carol Stocking, PhD, Jorg Cammenga, MD
Journal: Blood
Blood (2008) 112 (11): 1372.
https://doi.org/10.1182/blood.V112.11.1372.1372
Published: 2008
Journal Articles

Smad4 as a Therapeutic Target in Nup98-HoxA9-Induced Leukemia.

Ronan Quere, Ph.D., Goran Karlsson, Ph.D., Silja Andradottir, Marianne Rissler, Karin Olsson, Falk Hertwig, Kristian Reckzeh, MSc, Jorg Cammenga, MD, Ph.D., Stefan Karlsson, MD, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 1799.
https://doi.org/10.1182/blood.V112.11.1799.1799
Published: 2008
Journal Articles

Dissecting the Molecular Mechanisms of Mutant C/EBPalpha (p30) in Normal and Malignant Human Hematopoiesis.

Jorg Cammenga, MD, Birte Niebuhr, MS/BS, Stefan Horn, PhD, Ruud Delwel, PhD, Carol Stocking, PhD
Journal: Blood
Blood (2005) 106 (11): 2995.
https://doi.org/10.1182/blood.V106.11.2995.2995
Published: 2005
Journal Articles

The Role of RUNX1 DNA-Binding Mutations in Acute Myeloid Leukemia.

Jorg Cammenga, MD, Gabriela Putz, PhD, Birte Niebuhr, MS/BS, Stefan Horn, PhD, Ulla Bergholz, Frank Buchholz, PhD, Carol Stocking, PhD
Journal: Blood
Blood (2005) 106 (11): 1373.
https://doi.org/10.1182/blood.V106.11.1373.1373
Published: 2005